Page last updated: 2024-08-26

benzimidazolone and pimozide

benzimidazolone has been researched along with pimozide in 1 studies

*Pimozide: A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) [MeSH]

*Pimozide: A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baruchello, R; Costantini, C; Fochi, S; Grimaudo, S; Marchetti, P; Meli, M; Padroni, G; Pipitone, RM; Romagnoli, R; Rondanin, R; Simoni, D; Tolomeo, M1

Other Studies

1 other study(ies) available for benzimidazolone and pimozide

ArticleYear
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives.
    Bioorganic & medicinal chemistry letters, 2014, Sep-15, Volume: 24, Issue:18

    Topics: Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Fusion Proteins, bcr-abl; Humans; K562 Cells; Molecular Structure; Phosphorylation; Pimozide; STAT5 Transcription Factor; Structure-Activity Relationship

2014